Serum Institute of India looks beyond COVID with new vaccines for malaria, dengue
March 11, 2024 The CEO of the world’s biggest vaccine maker, Serum Institute of India, said the company has bolstered its manufacturing ahead of launches over the next few years…
More African countries set to approve malaria shot, 20 mln doses ready in 2023
April 21, 2023 African countries are lining up to approve a new vaccine for malaria, with 20 million doses available for them to buy this year, the shot’s manufacturer told…
Novavax completes process for WHO emergency use approval of COVID-19 vaccine
Nov. 5, 2021 Vaccine developer Novavax Inc said on Thursday it has completed the submission process for emergency use listing of its COVID-19 vaccine candidate with the World Health Organization….
COVID-19: Novavax vaccine receives first emergency use authorization
Nov. 1, 2021 Novavax Inc and partner Serum Institute of India said on Monday they received emergency use authorization for their COVID-19 vaccine in Indonesia, making it the first approval…
COVID-19: Pfizer, Moderna expected to reap billions of dollars from vaccine booster market
Aug 13, 2021 Drug makers Pfizer Inc, BioNTech and Moderna Inc are expected to reap billions of dollars from COVID-19 booster shots in a market that could rival the $6…
U.S. backs giving poorer countries access to COVID-19 vaccine patents, reversing stance
May 6, 2021 U.S. backs giving poorer countries access to COVID-19 vaccine patents, reversing stance President Joe Biden on Wednesday threw his support behind waiving intellectual property rights for COVID-19…